Several prominent institutional investors hold stakes in Intuitive Surgical (NASDAQ:ISRG), including Assenagon Asset Management S.a., Swedbank Ab, and Rathbone Brothers Plc. This concern is further amplified by increasing competition in cardiovascular devices and robotic surgery, particularly from companies such as Intuitive Surgical and Boston Scientific. What Investors Should Watch NextFor Medtronic (NYSE:MDT), investors will likely focus on whether management can sustain its turnaround momentum. The company expects fiscal 2027 organic revenue growth of 6.75% to 7.25%, including approximately 11.5% to 12% organic growth in Q1. For Intuitive Surgical (NASDAQ:ISRG), investors should continue monitoring da Vinci procedure growth, system placements, and adoption of newer platforms such as da Vinci 5.